Back

Re-classification of response to cardiac resynchronization therapy: the long-term effect of echocardiographic non-progression

7 April 2024 (08:30 - 15:00)
Organised by: Logo
Congress Presentation Part of: Cardiac resynchronisation therapy - conduction system pacing 3 Cardiac Resynchronisation Therapy (CRT) EHRA Premium Access EHRA 2024 European Heart Rhythm Association (EHRA)

About the speaker

Photo
Doctor Anett Behon

Semmelweis University Heart and Vascular Center, Budapest (Hungary)

7 More presentations in this session

Presentation thumbnail
Implant failure predictors of left bundle branch pacing used as cardiac resynchronization therapy: importance of left ventricular diameter and QRS morphology
Doctor F. Graterol Torres (Barcelona, ES)
Abstract Slides Video
Presentation thumbnail
Optimising electrical performance of leadless cardiac resynchronisation therapy and leadless LV septal pacing
Doctor N. Wijesuriya (London, GB)
Abstract Slides Video
Presentation thumbnail
LVSP and LBBP result in similar or improved LV synchrony and hemodynamics compared to biventricular pacing
Mr L. Poviser (Prague, CZ)
Abstract Slides Video
Presentation thumbnail
Clinical impact of ICD implantation in octogenarians: a longitudinal cohort study
Doctor M. Spoladori (Parma, IT)
Abstract Slides Video
Presentation thumbnail
Absence of late gadolinium enhancement and outcomes of cardiac resynchronization therapy in non-ischemic dilated cardiomyopathy
Doctor A. Di Marco (Barcelona, ES)
Abstract Slides Video

Access the full session

Session thumbnail
Cardiac resynchronisation therapy - conduction system pacing 3

The Event

Event poster

EHRA 2024

7 April - 9 April 2024
You may be interested in
thumbnail
Congress Presentation
Long-term outcome in non-progressors to cardiac resynchronization therapy
thumbnail
Congress Presentation
Cardiac resynchronization therapy - beyond ejection fraction
thumbnail
Congress Presentation
Identifying predictors of non-response to cardiac resynchronization therapy in heart failure patients

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources